Becton, Dickinson & Co. today named Dr. Ronald “Ron” Silverman as EVP and chief medical officer. He replaces BD Chief Medical Officer Dr. William Sigmund, who announced plans to retire from BD earlier this year. The change takes effect Dec. 4, 2023. Silverman comes from 3M Health Care, where he served as SVP and chief medical […]
BD
‘A safe pair of hands’ — Medtech’s investment in Ireland continues to grow
Medtech established its presence in Ireland many years ago and still, companies continue to invest in the ever-growing country. Boston Scientific established operations in Ireland in 1994, while Abbott has more than 70 years in the country. Medtronic, now officially headquartered in Dublin, has spent more than 40 years in Ireland and even hosted its […]
BD stock plummets on mixed Q4 results
BD shares took a hit this morning on fourth-quarter results that came in mixed compared to the consensus forecast. Shares of BDX fell 9.2% at $232.29 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell slightly. The Franklin Lakes, New Jersey-based company […]
BD launches next-gen needle-free blood draw tech
BD announced today that it launched new, FDA-cleared needle-free blood draw technology. The launch of the technology helps to further enable the company’s “One-Stick Hospital Stay” initiative. BD announced this initiative more than two years ago in an effort to transform the patient experience. With FDA 510(k) clearance, BD can now offer its new PIVO […]
BD appoints Greg Rodetis as SVP of investor relations
BD this week announced it appointed Greg Rodetis as SVP of investor relations, effective immediately. Rodetis is currently BD’s SVP and treasurer, so this appointment adds the head of investor relations to his responsibilities. He will continue as treasurer and lead all aspects of communicating the progress of BD’s strategy to investors. He will continue […]
The biggest medtech personnel moves so far in 2023
More than halfway through 2023, we’ve seen plenty of movement in the personnel department across medtech. Last July, we broke down the biggest personnel moves in medtech so far in 2022. That was followed up by the full-year report in December. Through more than eight months, the changes atop medtech companies continue to arrive. Some […]
BD enrolls first patient in study of stent graft for treating portal hypertension
BD (NYSE:BDX) announced today that it completed the enrollment of the first patient in a trial of its Liverty TIPS stent graft. Franklin Lakes, New Jersey-based BD’s ARCH FDA investigational device exemption (IDE) study evaluates the safety and effectiveness of Liverty. The global, prospective, multi-center, single-arm clinical study looks at the investigational device in the […]
Embecta increases 2023 guidance, reports closed-loop insulin delivery tech progress
Embecta (Nasdaq:EMBC) shares rose this morning as it increased its full-year guidance and shared an update on its automated insulin delivery technology. The company also reported third-quarter results that came in ahead of the consensus forecast. Shares of EMBC ticked up 3.1% at $22.27 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which […]
BD posts Street-beating Q3 driven by Medical, Interventional segments
BD shares fell slightly this morning on third-quarter results that topped the consensus forecast. Shares of BDX dipped 0.7% at $274.35 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 0.8%. The Franklin Lakes, New Jersey–based medtech company posted profits of $392 […]
Steris completes acquisition of surgical instrumentation assets from BD
Steris (NYSE:STE) announced today that it completed its acquisition of surgical instrumentation assets from BD . The companies announced in June that they agreed on a deal for the assets worth $540 million. BD’s divestiture includes V. Mueller, Snowden-Pencer and Genesis branded products. BD reports its surgical instrumentation platform as part of its Surgery unit […]
FDA clears BD combo test for COVID-19, flu, RSV
BD announced today that the FDA granted 510(k) clearance for its respiratory viral panel (RVP). Franklin Lakes, New Jersey-based BD designed the RVP for its BD Max system as a single molecular diagnostic that identifies a number of viruses. It distinguishes SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) in approximately two hours. […]